INCREASED SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA TO CIPROFLOXACIN IN THE PRESENCE OF VANCOMYCIN

被引：14

作者：

DAY, CA

MARCEAUDAY, ML

DAY, DF

机构：

[1] ST JOSEPHS ACAD,BATON ROUGE,LA 70803

[2] LOUISIANA STATE UNIV,CTR ADV MICROSTRUCT & DEVICES,BATON ROUGE,LA 70803

[3] LOUISIANA STATE UNIV,AUDUBON SUGAR INST,SUGAR STN,BATON ROUGE,LA 70803

[4] LOUISIANA STATE UNIV,AGR EXPT STN,BATON ROUGE,LA 70803

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1993年 / 37卷 / 11期

关键词：

D O I：

10.1128/AAC.37.11.2506

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Vancomycin in combination with ciprofloxacin exhibited synergy against 7 of 10 strains of Pseudomonas aeruginosa. MICs for the microbial strains used in this study ranged from 0.0325 to 3.0 mug/ml for ciprofloxacin and from 23.5 to >188 mug/ml for vancomycin. Combinations of these antibiotics, tested in a checkerboard pattern, gave fractional inhibitory concentrations of 0.5 or less for 7 of the 10 strains tested.

引用

收藏

页码：2506 / 2508

页数：3

相关论文

共 18 条

[1] SYNERGY OF CIPROFLOXACIN AND AZLOCILLIN INVITRO AND IN A NEUTROPENIC MOUSE MODEL OF INFECTION [J].

CHIN, NX ;

JULES, K ;

NEU, HC .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (01) :23-28

[2] ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI [J].

COHEN, SP ;

HOOPER, DC ;

WOLFSON, JS ;

SOUZA, KS ;

MCMURRY, LM ;

LEVY, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1187-1191

[3] INVESTIGATIONS INTO THE MECHANISM OF ACTION OF THE ANTIBACTERIAL AGENT NORFLOXACIN [J].

CRUMPLIN, GC ;

KENWRIGHT, M ;

HIRST, T .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 :9-23

[4] MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI .3. CONDITIONS REQUIRED FOR LETHALITY [J].

DEITZ, WH ;

COOK, TM ;

GOSS, WA .

JOURNAL OF BACTERIOLOGY, 1966, 91 (02) :768-&

[5] STUDIES ON THE SYNERGISM OF CIPROFLOXACIN WITH BETA-LACTAM ANTIBIOTICS, GENTAMICIN, MINOCYCLINE AND PIPEMIDIC ACID [J].

DICKGIESSER, N ;

STROTH, SID ;

WUNDT, W .

INFECTION, 1986, 14 (02) :82-85

[6]

Gadebusch H H, 1991, Int J Antimicrob Agents, V1, P3, DOI 10.1016/0924-8579(91)90019-A

[7] DNA TOPOISOMERASES [J].

GELLERT, M .

ANNUAL REVIEW OF BIOCHEMISTRY, 1981, 50 :879-910

[8] ISOLATION AND CHARACTERIZATION OF NORFLOXACIN-RESISTANT MUTANTS OF ESCHERICHIA-COLI K-12 [J].

HIRAI, K ;

AOYAMA, H ;

SUZUE, S ;

IRIKURA, T ;

IYOBE, S ;

MITSUHASHI, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :248-253

[9] GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF NORFLOXACIN RESISTANCE IN ESCHERICHIA-COLI [J].

HOOPER, DC ;

WOLFSON, JS ;

SOUZA, KS ;

TUNG, C ;

MCHUGH, GL ;

SWARTZ, MN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :639-644

[10] OUTER-MEMBRANE ALTERATIONS IN MULTIRESISTANT MUTANTS OF PSEUDOMONAS-AERUGINOSA SELECTED BY CIPROFLOXACIN [J].

LEGAKIS, NJ ;

TZOUVELEKIS, LS ;

MAKRIS, A ;

KOTSIFAKI, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) :124-127